Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

阿尔法2等离子素抑制剂缺乏症

B Lipinski, V Gurewich

    Lancet (London, England)
    |February 10, 1979
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects: comment.

    Journal of thrombosis and haemostasis : JTH·2017
    Same author

    Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.

    Journal of thrombosis and thrombolysis·2017
    Same author

    Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII: comment.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Structure-function relationships in thrombin-activatable fibrinolysis inhibitor: comment.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Differences in morphology of fibrin clots induced with thrombin and ferric ions and its pathophysiological consequences.

    Heart, lung & circulation·2012
    Same author

    Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron.

    Hematology (Amsterdam, Netherlands)·2012